Ignite — Tesamorelin
Back to Catalog

Ignite

Tesamorelin

Body composition, transformed.

Rp 1.800.000
10mg per vial
20%Off

Bundle offer

Mix any 3+ products

Quantities count. Discount applies to every eligible item.

Bacteriostatic water is excluded and does not count toward the 3.

Also available as

Pre-filled penIGNITETesamorelinRp 2.600.00010 mg

Order Inclusions

1 × 3mL BAC WaterIncluded
Free instant deliveryDelivered today
Alcohol wipes & syringesIncluded

What it does for you

  1. Encourages your body to produce more of its own growth hormone, naturally
  2. Targets the stubborn fat stored around your organs, not just under the skin
  3. Helps balance cholesterol and fat levels in the blood
  4. Speeds up your resting metabolism so your body burns more at baseline

Tesamorelin Research Notes

What is Tesamorelin?

Tesamorelin is a synthetic analogue of growth hormone releasing hormone (GHRH) — the endogenous peptide that stimulates the pituitary gland to produce and release growth hormone. It is one of the few peptides in this category with a meaningful human clinical data record — it received FDA approval under the brand name Egrifta for HIV-associated lipodystrophy in 2010, making it one of the most clinically validated GHRH analogues available.

Unlike direct GH administration, tesamorelin stimulates the pituitary to produce GH in natural pulses — preserving the body's own feedback mechanisms rather than bypassing them.

What the research shows

  • Visceral fat reduction: Phase III trials in HIV-associated lipodystrophy showed significant reductions in visceral adipose tissue versus placebo over 26 weeks.

  • GH axis: Clinical studies consistently show elevated IGF-1 levels, confirming downstream activation of the GH axis.

  • Cognitive function: A randomised controlled trial in older adults with mild cognitive impairment (Baker et al., 2012) reported improvements in cognitive function versus placebo — an increasingly studied application.

  • Body composition: Clinical studies document improvements in the lean-mass-to-fat ratio alongside reductions in visceral fat.

Reference: Falutz J. et al. (2010). NEJM, 357(23), 2349–2361.

Ordering Tesamorelin in Bali

Tesamorelin is not a controlled substance under Indonesian BPOM regulations. Same-day delivery may be possible only after the team confirms the exact item, current availability, route, daily cutoff, complete villa or hotel address, and timing before ordering.

Common Questions

Q: How does tesamorelin differ from ipamorelin or CJC-1295?

Tesamorelin is a GHRH analogue that acts on the GHRH receptor. Ipamorelin is a GHRP that acts on the ghrelin receptor. CJC-1295 is also a GHRH analogue but has a longer half-life. Tesamorelin has the most extensive human clinical data of the three.

Q: Is it commonly stacked?

It is sometimes researched alongside ipamorelin for a dual-pathway GH stimulation protocol, with GHRH and GHRP acting on complementary receptors.

Q: Storage?

Refrigerate at 2–8°C. Use within 28 days of reconstitution. Ships cold-packed.

Research by goal

Explore Tesamorelin in context

Read the relevant goal guides to understand the research area, adjacent compounds, and the questions each track explores.

View all goals